These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

822 related articles for article (PubMed ID: 19573774)

  • 1. Quality of care indicators for prostate cancer: progress toward consensus.
    Miller DC; Saigal CS
    Urol Oncol; 2009; 27(4):427-34. PubMed ID: 19573774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the quality of prostate cancer care.
    Penson DF
    Curr Opin Urol; 2008 May; 18(3):297-302. PubMed ID: 18382239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring the quality of care for localized prostate cancer.
    Miller DC; Montie JE; Wei JT
    J Urol; 2005 Aug; 174(2):425-31. PubMed ID: 16006858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-of-care indicators for early-stage prostate cancer.
    Spencer BA; Steinberg M; Malin J; Adams J; Litwin MS
    J Clin Oncol; 2003 May; 21(10):1928-36. PubMed ID: 12743145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in quality of care for men with early-stage prostate cancer.
    Spencer BA; Miller DC; Litwin MS; Ritchey JD; Stewart AK; Dunn RL; Gay EG; Sandler HM; Wei JT
    J Clin Oncol; 2008 Aug; 26(22):3735-42. PubMed ID: 18669460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment choice and quality of care for men with localized prostate cancer.
    Miller DC; Spencer BA; Ritchey J; Stewart AK; Dunn RL; Sandler HM; Wei JT; Litwin MS
    Med Care; 2007 May; 45(5):401-9. PubMed ID: 17446826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the quality of medical care among patients with early stage prostate cancer undergoing expectant management in the United States.
    Ritchey J; Gay EG; Spencer BA; Miller DC; Wallner LP; Stewart AK; Dunn RL; Litwin MS; Wei JT
    J Urol; 2012 Sep; 188(3):769-74. PubMed ID: 22818140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of the Quality Oncology Practice Initiative at a university comprehensive cancer center.
    Blayney DW; McNiff K; Hanauer D; Miela G; Markstrom D; Neuss M
    J Clin Oncol; 2009 Aug; 27(23):3802-7. PubMed ID: 19487377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of quality indicators to evaluate the care of patients with localized prostate carcinoma.
    Miller DC; Litwin MS; Sanda MG; Montie JE; Dunn RL; Resh J; Sandler H; Wei JT
    Cancer; 2003 Mar; 97(6):1428-35. PubMed ID: 12627506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to prostate cancer by managed care organizations.
    Bennett CL; Buchner DA; Ullman M
    Urology; 1997 Jul; 50(1):79-86. PubMed ID: 9218023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate quality of care indicators for localized bladder cancer.
    Cooperberg MR; Porter MP; Konety BR
    Urol Oncol; 2009; 27(4):435-42. PubMed ID: 19573775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A process for measuring the quality of cancer care: the Quality Oncology Practice Initiative.
    Neuss MN; Desch CE; McNiff KK; Eisenberg PD; Gesme DH; Jacobson JO; Jahanzeb M; Padberg JJ; Rainey JM; Guo JJ; Simone JV
    J Clin Oncol; 2005 Sep; 23(25):6233-9. PubMed ID: 16087948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of prostate cancer quality indicators: a modified Delphi approach.
    Gagliardi AR; Fleshner N; Langer B; Stern H; Brown AD
    Can J Urol; 2005 Oct; 12(5):2808-15. PubMed ID: 16274516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of prostate carcinoma care in a statewide public assistance program.
    Krupski TL; Bergman J; Kwan L; Litwin MS
    Cancer; 2005 Sep; 104(5):985-92. PubMed ID: 16047332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National assessment of melanoma care using formally developed quality indicators.
    Bilimoria KY; Raval MV; Bentrem DJ; Wayne JD; Balch CM; Ko CY
    J Clin Oncol; 2009 Nov; 27(32):5445-51. PubMed ID: 19826131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The critical limitations of volume-outcome analysis.
    Ellison L
    Urol Oncol; 2009; 27(4):422-6. PubMed ID: 19573773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing performance measurement in oncology.
    Campion FX; Larson LR; Kadlubek PJ; Earle CC; Neuss MN
    Am J Manag Care; 2011 May; 17 Suppl 5 Developing():SP32-6. PubMed ID: 21711075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance measurement in prostate cancer care: beyond report cards.
    Ullman M; Metzger CK; Kuzel T; Bennett CL
    Urology; 1996 Mar; 47(3):356-65. PubMed ID: 8633402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using QRRO survey data to assess compliance with quality indicators for breast and prostate cancer.
    Owen JB; White JR; Zelefsky MJ; Wilson JF
    J Am Coll Radiol; 2009 Jun; 6(6):442-7. PubMed ID: 19467491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of quality indicators for patients undergoing colorectal cancer surgery.
    McGory ML; Shekelle PG; Ko CY
    J Natl Cancer Inst; 2006 Nov; 98(22):1623-33. PubMed ID: 17105985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.